Bristol-Myers Squibb to Take Part in UBS 2018 Global Healthcare Conference
NEW YORK--(BUSINESS WIRE)--May 15, 2018--Bristol-Myers Squibb Company (NYSE:BMY) will take part in the UBS 2018 Global Healthcare Conference on Tuesday, May 22, 2018, in New York. Charles Bancroft, executive vice president, Chief Financial Officer and Head of Global Business Operations, will answer questions about the company at 11:30 a.m. ET.
Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180515005034/en/
CONTACT: Bristol-Myers Squibb Company
Ken Dominski, 609-252-5251
Bill Szablewski, 609-252-5894
KEYWORD: UNITED STATES NORTH AMERICA NEW YORK
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL FDA
SOURCE: Bristol-Myers Squibb
Copyright Business Wire 2018.
PUB: 05/15/2018 06:59 AM/DISC: 05/15/2018 06:59 AM